Home →
Resource →
A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay
A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay
ttp://www.ideas-itn.eu/wp-content/uploads/2018/08/Eleni_PSI_2018.pdf
pdf
Eleni Vradi, Thomas Jaki, Werner Brannath & Ricahard Vonk. PSI, 4th June 2018 (Amsterdam)
Share this page
share using:
Or copy and paste this page address:
https://www.ideas-itn.eu/resources/a-bayesian-model-to-estimate-the-cutoff-and-the-clinical-utility-of-a-biomarker-assay/